SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

NCT02944019 ·Status: COMPLETED

Study of DU-176b Aged 80 Years or Older

NCT02801669 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

NCT03649152 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease

NCT00443287 ·Status: COMPLETED ·Phase: PHASE2

Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease

NCT03718559 ·Status: COMPLETED ·Phase: PHASE4

A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

NCT01715818 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease

NCT02393612 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

NCT01806077 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

NCT05856487 ·Status: UNKNOWN ·Phase: PHASE3

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

NCT01730534 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

NCT06046196 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

NCT04848220 ·Status: TERMINATED ·Phase: PHASE2

A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

NCT07301034 ·Status: RECRUITING ·Phase: PHASE3

Cardiovascular Inflammation Reduction Trial

NCT01594333 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease

NCT00491543 ·Status: COMPLETED ·Phase: PHASE2

Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

NCT01612884 ·Status: TERMINATED ·Phase: PHASE4

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

NCT03950843 ·Status: UNKNOWN ·Phase: PHASE3

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

NCT00617123 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

NCT01157156 ·Status: COMPLETED ·Phase: PHASE1

Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

NCT02298088 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.

NCT00798005 ·Status: COMPLETED ·Phase: PHASE2

REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD

NCT05912218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension

NCT03254446 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran

NCT01955720 ·Status: COMPLETED ·Phase: PHASE1

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651 ·Status: COMPLETED ·Phase: PHASE4